4//SEC Filing
CORE LABORATORIES N V 4
Accession 0001000229-15-000061
CIK 0001000229operating
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:05 PM ET
Size
10.0 KB
Accession
0001000229-15-000061
Insider Transaction Report
Form 4
Ogren D John
Director
Transactions
- Tax Payment
Common Shares
2015-03-31$104.49/sh−5$522→ 40,424 total - Award
Restricted Shares
2015-04-01+1,436→ 1,436 totalExercise: $0.00→ Common Shares (1,436 underlying) - Exercise/Conversion
Restricted Shares
2015-03-31−1,141→ 0 totalExercise: $0.00→ Common Shares (1,141 underlying) - Exercise/Conversion
Common Shares
2015-03-31+1,141→ 40,429 total
Footnotes (2)
- [F1]The Restricted Shares vested at the end of a three-year vesting period ending March 31, 2015.
- [F2]The Restricted Shares will vest, without performance criteria, at the end of a three-year vesting period ending March 31, 2018, subject to the terms of issuance.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeoperating
IncorporatedNetherlands
Related Parties
1- filerCIK 0001000229
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:05 PM ET
- Size
- 10.0 KB